Cas:1142194-75-9 1-(2-bromopyridin-4-yl)pyrrolidin-2-one manufacturer & supplier

We serve Chemical Name:1-(2-bromopyridin-4-yl)pyrrolidin-2-one CAS:1142194-75-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(2-bromopyridin-4-yl)pyrrolidin-2-one

Chemical Name:1-(2-bromopyridin-4-yl)pyrrolidin-2-one
CAS.NO:1142194-75-9
Synonyms:1-(2-bromopyridin-4-yl)pyrrolidin-2-one
Molecular Formula:C9H9BrN2O
Molecular Weight:241.08500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:33.20000
Exact Mass:239.99000
LogP:2.03590

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-(2-bromopyridin-4-yl)pyrrolidin-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2-bromopyridin-4-yl)pyrrolidin-2-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2-bromopyridin-4-yl)pyrrolidin-2-one Use and application,1-(2-bromopyridin-4-yl)pyrrolidin-2-one technical grade,usp/ep/jp grade.


Related News: Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). 1-(2-bromopyridin-4-yl)pyrrolidin-2-one manufacturer The April halt followed the discovery that ingredients from AstraZeneca’s (AZN.L) COVID-19 vaccine, also being produced at the plant at the time, contaminated a batch of J&J’s vaccine. AstraZeneca’s shot is no longer being made there. 1-(2-bromopyridin-4-yl)pyrrolidin-2-one supplier Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies. 1-(2-bromopyridin-4-yl)pyrrolidin-2-one vendor Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies. 1-(2-bromopyridin-4-yl)pyrrolidin-2-one factory Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent).